Ferroportin in the Progression and Prognosis of Hepatocellular Carcinoma

European Journal of Medical Research - United Kingdom
doi 10.1186/2047-783x-18-59
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Neutrophils: Driving Progression and Poor Prognosis in Hepatocellular Carcinoma?

British Journal of Cancer
Cancer ResearchOncology
2017English

A Case of Ferroportin Disease B Complicated With Hepatocellular Carcinoma

Acta Hepatologica Japonica
Hepatology
2017English

MicroRNAs in Hepatocellular Carcinoma: Carcinogenesis, Progression, and Therapeutic Target

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2014English

Circular RNA 0016788 Displays as a Biomarker for Tumor Progression and Poor Prognosis in Surgical Hepatocellular Carcinoma Patients

Journal of Clinical Laboratory Analysis
AllergyImmunologyBiochemistryPublic HealthMedical Laboratory TechnologyClinical BiochemistryHematologyMicrobiologyEnvironmentalOccupational Health
2020English

Risk Factors and Prognosis of Spontaneously Ruptured Hepatocellular Carcinoma in Thailand

Asian Pacific Journal of Cancer Prevention
2018English

Impact of SS18l1 Polymorphism in Predicting Prognosis of Hepatocellular Carcinoma

HPB
HepatologyGastroenterology
2018English

Downregulation of GNA14 in Hepatocellular Carcinoma Indicates an Unfavorable Prognosis

Oncology Letters
Cancer ResearchOncology
2020English

HSP90 Interacts With HMGCR and Promotes the Progression of Hepatocellular Carcinoma

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

Relationship Between Survivin Expression and Recurrence, and Prognosis in Hepatocellular Carcinoma

World Journal of Gastroenterology
MedicineGastroenterology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy